Sutent - analogs
Components: Sunitinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: 153.1-1937.3€ Instructions Sutent | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Tautax ✘ (incl) Паклитаксел-ДЕКО ✘ (incl) Bursae pastoris herba ✘ (incl) Фитофим №3 ✘ (incl) Motherwort herb tincture ✘ (incl) Zinc bisvinylimidazole diacetate ✘ (incl) Мед с экстрактом женьшеня ✘ (incl) Валерианы экстракт сухой ✘ (incl) Hydroxyzine ✘ (incl) Doxorubicin hydrochloride ✘ (incl) Strychnos gaultheria ✘ (incl) Компьютер-айз ✘ (incl) Grippex ✘ (incl) Cytotec ✘ (incl) Ren suis ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Sunitinib-nativ Dangerous 🔍 | 2016.2€ |
≈100% | Sunitinib Dangerous 🔍 | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 47% 882-1043.3€ Votrient Negative 🔍 [Pazopanib]
- 47% — Pazopanib Negative 🔍 [Pazopanib]
- 47% — Амезопан Negative 🔍 [Pazopanib]
- 47% — Pazopanib-TL Negative 🔍 [Pazopanib]
- 47% — ПОТАРБИН Negative 🔍 [Pazopanib]
- 44% — Сорафениб геми-тозилат моногидрат Negative 🔍 [Sorafenib]
- 44% 830-1485.8€ Nexavar Negative 🔍 [Sorafenib]
- 44% — Сорафениба тозилат Negative 🔍 [Sorafenib]
- 44% — Сорафениб-натив Negative 🔍 [Sorafenib]
- 44% — Сорафениб-промомед Negative 🔍 [Sorafenib]
- 44% — Сорафениб-АМЕДАРТ Negative 🔍 [Sorafenib]
- 44% — Флутриксан Negative 🔍 [Sorafenib]
- 44% — Пазопаниба гидрохлорид Negative 🔍 [Pazopanib]
- 44% 3936.6€ Кабометикс Negative 🔍 [Cabozantinib]
- 41% 1732.5€ Lenvima No 🔍 [Lenvatinib]
- 38% — Multihance neutral [Gadobenic acid and more 1Meglumine]
- 38% — Дорипенем Эльфа neutral [Doripenem]
- 38% — Sanocef neutral [Doripenem]
- 38% — АГГРАСТАТ neutral [Tirofiban]
- 38% — XeMed neutral [Xenon]
- 38% 210€ Doriprex neutral [Doripenem]
- 36% — Иматиниб-Сигардис Dangerous 🔍 [Imatinib]
- 36% — Албитиниб Dangerous 🔍 [Imatinib]
- 36% — Imatinib Dangerous 🔍 [Imatinib]
- 36% 590-1010€ Zelboraf neutral [Vemurafenib and more 1Hypromellose]
- 36% 190.2-195.7€ Зенлистик neutral [Abemaciclib]
- 35% — Sorafenib Negative 🔍 [Sorafenib]
- 35% 862.9€ Vargatef neutral [Nintedanib]
- 33% — Doripenem MD neutral [Doripenem]
- 33% 42.3-61€ Philachromin FS Dangerous 🔍 [Imatinib]
- 33% 114.4-127.7€ Glivec Dangerous 🔍 [Imatinib]
- 33% — Doripenem neutral [Doripenem]
- 33% — Доренем neutral [Doripenem]
- 33% — Дорипенем Дж neutral [Doripenem]
- 32% — Tallii chloridum, 201 Tl neutral
- 32% — Monafram neutral [F(ab)2 фрагменты антител моноклональных FRaMon]
- 31% — Молсидомин-СЗ neutral [Molsidomine]
- 31% — Воздушно-ксеноновая смесь с радиоизотопом ксенон-133 neutral [Xenon]
- 31% 3.1€ Molsidomin-Lekpharm neutral [Molsidomine]
- 31% — Medxenon neutral [Xenon]
- 31% — Ксенон-133, в изотоническом растворе neutral [Xenon]
- 31% — Xenon neutral [Xenon]
- 31% 2.3-3€ Sydnopharm neutral [Molsidomine]
- 30% 3.3€ Panangin Negative 🔍 [Potassium aspartate and more 1Magnesium aspartate]
- 29% 0.7-2.8€ Cardiket neutral [Isosorbide dinitrate]
- 29% 865.5€ Dupixent neutral [Dupilumab]
- 29% — Тикагрелор neutral [Ticagrelor]
- 29% 38.2€ Integrilin neutral [Eptifibatide]
- 29% 14-56.5€ Koromax neutral [Eptifibatide]
- 29% — Iso Mack retard neutral [Isosorbide dinitrate]
Learn more about the selection of analogues
- The drug has «Sutent» 5 full analogs, the cheapest - Sunitinib-nativ (2016.2€); 51 analog by action, the most similar - Votrient (882-1043.3€).
- Medical online service has selected the best substitutes for Sutent based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Sutent analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.